The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Anexate 500 micrograms/5ml, solution for injection or infusion

Cheplapharm Arzneimittel GmbHPA1868/002/001

Main Information

Trade NameAnexate 500 micrograms/5ml, solution for injection or infusion
Active SubstancesFlumazenil
Dosage FormSolution for injection/infusion
Licence HolderCheplapharm Arzneimittel GmbH
Licence NumberPA1868/002/001

Group Information

ATC CodeV03AB Antidotes
V03AB25 flumazenil


License statusAuthorised
Licence Issued18/02/1988
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back